Date post: | 01-Jan-2016 |
Category: |
Documents |
Upload: | ignacia-price |
View: | 18 times |
Download: | 0 times |
Compliance With Anticoagulants
Terminology and Definitions
ROCKET AF: Patients Off Study Drug Are at Increased Risk of Stroke and Non-CNS Embolism
Slight Benefit in First Year Post-Trial: No Harm or Benefit Years 2-5+
Features of NOACs
Dosing Considerations: Summary
Compliance to Therapy
Factors Related to Compliance
Compliance With OD vs BID Regimens Is Generally Better for
Chronic Conditions
Patient Enrollment
Antithrombotic Treatment According
to CHA2DS2-VASc Score
Antithrombotic Therapy According to
AF Clinical Presentation
Antithrombotic Therapy in AF: Real-World Clinical Characteristics in Japan
J-ROCKET AF: Principal Safety Outcome
Major or Non-Major Clinically Relevant Bleeding
J-ROCKET AF: Primary Efficacy End Point
Stroke and Non-CNS Systemic Embolism
NOACs: Agenda for Outpatient Visits
AEGEAN Study: Impact of Educational Program on Patient Adherence to Apixaban
Summary
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
References
References (cont)
References (cont)
References (cont)